Elizabeth Trehu insider trades: Jounce Therapeutics (JNCE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elizabeth reports to the SEC
Open-market buys and sales
10 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | JNCE | ↓ Sell | 9,285 | $1.11 | $10K | Direct | Jan 11, 2023 (1d) |
| Jan 10, 2022 | JNCE | ↓ Sell | 8,383 | $6.88 | $58K | Direct | Jan 11, 2022 (1d) |
| Mar 31, 2021 | JNCE | ↓ Sell | 13,500 | $10.09 | $136K | Direct | Mar 31, 2021 (0d) |
| Jan 20, 2021 | JNCE | ↓ Sell | 6,500 | $12.01 | $78K | Direct | Jan 22, 2021 (2d) |
| Jan 8, 2021 | JNCE | ↓ Sell | 5,298 | $6.89 | $36K | Direct | Jan 11, 2021 (3d) |
| Aug 17, 2020 | JNCE | ↓ Sell | 2,182 | $4.71 | $10K | Direct | Aug 18, 2020 (1d) |
| Jan 7, 2020 | JNCE | ↓ Sell | 2,624 | $7.78 | $20K | Direct | Jan 10, 2020 (3d) |
| Aug 16, 2019 | JNCE | ↓ Sell | 2,336 | $3.99 | $9K | Direct | Aug 16, 2019 (0d) |
| Mar 8, 2018 | JNCE | ↓ Sell | 4,545 | $25.06 | $114K | Direct | Mar 12, 2018 (4d) |
| Mar 5, 2018 | JNCE | ↓ Sell | 4,545 | $21.50 | $98K | Direct | Mar 7, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Elizabeth Trehu's insider trades
Elizabeth Trehu is Chief Medical Officer at Jounce Therapeutics (JNCE). Since Mar 5, 2018, Elizabeth has reported no open-market purchases and 10 sales worth $570K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), option exercises (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.